On October 5, 2026 Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported that company management will participate in the following investor conferences in October 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Fall Focus: Barclays Biotech 1×1 Day
Format: 1×1 Meetings
Date: Tuesday, October 6, 2026
Location: New York, NY

Event: Investment Generation Conference
Format: Presentation
Date: Thursday, October 15, 2026
Time: 12:30 – 1:00 PM
Location: Rishon Letzion, Israel

(Press release, Alpha Tau Medical, OCT 5, 2026, View Source [SID1234673208])